Peter Flachenecker
Impact in
- Pathology and Forensic Medicine top 0.2%
- Multiple Sclerosis Research Studies
- Neurology top 2%
- Botulinum Toxin and Related Neurological Disorders
- Peripheral Neuropathies and Disorders
Papers in
-
- Multiple Sclerosis Research Studies 111
- Neurology 18
- Botulinum Toxin and Related Neurological Disorders 8
- Peripheral Neuropathies and Disorders 7
- Co-authors
- Uwe Klaus Zettl (35 shared papers)Karlheinz Reiners (14 shared papers)Klaus Victor Toyka (8 shared papers)Thomas Henze (17 shared papers)Marlene Gottschalk (2 shared papers)Claudia Trenkwalder (2 shared papers)Tania Kümpfel (2 shared papers)Klaus Viktor Toyka (6 shared papers)
In The Last Decade
Peter Flachenecker
134 papers receiving 4.5k citations
Peter Flachenecker's Hit Papers
Peers
Comparison fields: 5 of 111
- Pathology and Forensic Medicine 3.1k
- Neurology 565
- Physical Therapy, Sports Therapy and Rehabilitation 143
- Pharmacology 224
- Neurology 109
Countries citing papers authored by Peter Flachenecker
This map shows the geographic impact of Peter Flachenecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Flachenecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Flachenecker more than expected).
Fields of papers citing papers by Peter Flachenecker
This network shows the impact of papers produced by Peter Flachenecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Flachenecker. The network helps show where Peter Flachenecker may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Flachenecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 530 | |
| 2 | 2001 | 410 | |
| 3 | Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Hit paper breakdown → | 2018 | 286 |
| 4 | 2007 | 172 | |
| 5 | 2004 | 140 | |
| 6 | 2014 | 136 | |
| 7 | 2001 | 130 | |
| 8 | 2018 | 122 | |
| 9 | 1997 | 109 | |
| 10 | 2003 | 108 | |
| 11 | 2005 | 108 | |
| 12 | 2005 | 105 | |
| 13 | 1999 | 98 | |
| 14 | 2005 | 98 | |
| 15 | 2013 | 98 | |
| 16 | 2005 | 89 | |
| 17 | 2009 | 81 | |
| 18 | 2008 | 80 | |
| 19 | 2006 | 68 | |
| 20 | 2017 | 67 |
About Peter Flachenecker
Peter Flachenecker is a scholar working on Pathology and Forensic Medicine, Neurology, Urology, Physical Therapy, Sports Therapy and Rehabilitation and Family Practice, having authored 152 papers that have together received 4.9k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (111 papers), Heart Rate Variability and Autonomic Control (9 papers), Botulinum Toxin and Related Neurological Disorders (8 papers), Peripheral Neuropathies and Disorders (7 papers), Urinary Bladder and Prostate Research (6 papers), Cardiovascular Syncope and Autonomic Disorders (5 papers), Cannabis and Cannabinoid Research (5 papers) and Medical research and treatments (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Neurology (565 citations), Physical Therapy, Sports Therapy and Rehabilitation (143 citations), Pharmacology (224 citations) and Neurology (109 citations). Peter Flachenecker has collaborated with scholars based in Germany, Austria and Spain. Frequent co-authors include Uwe Klaus Zettl, Karlheinz Reiners, Klaus Victor Toyka, Thomas Henze, Marlene Gottschalk, Claudia Trenkwalder, Tania Kümpfel, Klaus Viktor Toyka, Boris A. Kallmann and Oliver Martin Grauer. Their work appears in journals such as Multiple Sclerosis Journal, Journal of Neurology, Multiple Sclerosis and Related Disorders, Health and Quality of Life Outcomes and Acta Neurologica Scandinavica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.